Follow-up COVID-19 and Lung Ultrasound are Fundamental to Prove
Full Recovery in Children with Interstitial Lung Disease Requiring Oxygen:
A Case Report

Marcella      Contieri; Cristiana      Indolfi; Sossio      Vitale; Angela      Klain; Giulio      Dinardo; Fabio      Decimo; Michele   Miraglia   del Giudice

doi:10.2174/1573398X19666230314161859

Abstract

Background: Children with mild or asymptomatic COVID-19 represent the majority of paediatric cases. Hospitalisation and critical care are required only in a small proportion of SARSCoV- 2 positive children who present severe symptoms, like interstitial lung disease. A quarter of children experience persistent symptoms some months later after being hospitalised, and they need to be properly followed up.

Case Presentation: The authors describe a case report of long-COVID in a 5 years old child, who was previously hospitalized for a severe case of COVID-19 (an interstitial lung disease requiring oxygen), followed up in 3 months in our Pediatric Department.

Results: After 3 months post-hospitalisation, despite his clinic history, the clinical examination was normal, during the six-minute walking test he did not desaturate, the spirometry was in the norm and the lung ultrasound did not show any pathological findings.

Conclusion: We reported a case of a child previously hospitalised for interstitial lung disease with long-COVID, who has been followed up 3 months after the hospitalisation by our Department of Pediatrics of the University ‘Luigi Vanvitelli’. Based on our experience, even in children who have experienced a severe form of COVID-19 disease and who continue to exhibit symptoms, a proper follow-up can demonstrate a full recovery in a few months.

« Previous Next »

Graphical Abstract

[1]
Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur Respir J  2022; 59(2): 2101341.
 [http://dx.doi.org/10.1183/13993003.01341-2021] [PMID:  34210789]

[2]
Viner RM, Ward JL, Hudson LD, et al. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch Dis Child  2021; 106(8): 802-7.
 [http://dx.doi.org/10.1136/archdischild-2020-320972] [PMID:  33334728]

[3]
Parisi GF, Brindisi G, Indolfi C, et al. Upper airway involvement in pediatric COVID-19. Pediatr Allergy Immunol  2020; 31(S26): 90-117.
 [http://dx.doi.org/10.1111/pai.13356]

[4]
Parisi GF, Brindisi G, Indolfi C, et al. COVID‐19, anosmia, and ageusia in atopic children. Pediatr Allergy Immunol  2022; 33 (Suppl. 27): 99-101.
 [http://dx.doi.org/10.1111/pai.13644] [PMID:  35080301]

[5]
Cui X, Zhao Z, Zhang T, et al. A systematic review and meta‐analysis of children with coronavirus disease 2019 (COVID‐19). J Med Virol  2021; 93(2): 1057-69.
 [http://dx.doi.org/10.1002/jmv.26398] [PMID:  32761898]

[6]
Parcha V, Booker KS, Kalra R, et al. A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States. Sci Rep  2021; 11(1): 10231.
 [http://dx.doi.org/10.1038/s41598-021-89553-1] [PMID:  33986390]

[7]
Parisi GF, Indolfi C, Decimo F, Leonardi S, Miraglia del Giudice M. COVID-19 pneumonia in children: From etiology to management. Front Pediatr  2020; 8: 616622.
 [http://dx.doi.org/10.3389/fped.2020.616622] [PMID:  33381482]

[8]
Taboada M, Cariñena A, Moreno E, et al. Post-COVID-19 functional status six-months after hospitalization. J Infect  2021; 82(4): e31-3.
 [http://dx.doi.org/10.1016/j.jinf.2020.12.022] [PMID:  33373650]

[9]
Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine  2021; 31: 100683.
 [http://dx.doi.org/10.1016/j.eclinm.2020.100683] [PMID:  33490928]

[10]
Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol  2021; 93(2): 1013-22.

[11]
Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: A multinational, multicentre cohort study. Lancet Child Adolesc Health  2020; 4(9): 653-61.
 [http://dx.doi.org/10.1016/S2352-4642(20)30177-2] [PMID:  32593339]

[12]
Howard-Jones AR, Burgner DP, Crawford NW, et al. COVID-19 in children. II: Pathogenesis, disease spectrum and management. J Paediatr Child Health  2021; 58(1): 46-53.
 [http://dx.doi.org/10.1111/jpc.15811] [PMID:  34694037]

[13]
Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr  2021; 15(3): 869-75.
 [http://dx.doi.org/10.1016/j.dsx.2021.04.007] [PMID:  33892403]

[14]
Parisi GF, Diaferio L, Brindisi G, et al. Cross-sectional survey on long term sequelae of pediatric COVID-19 among italian pediatricians. Children  2021; 8(9): 769.
 [http://dx.doi.org/10.3390/children8090769] [PMID:  34572201]

[15]
Kikkenborg Berg S, Palm P, Nygaard U, et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc Health  2022; 6(9): 614-23.

[16]
Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis  2021; 53(10): 737-54.
 [http://dx.doi.org/10.1080/23744235.2021.1924397] [PMID:  34024217]

[17]
Manti S, Licari A. How to obtain informed consent for research. Breathe  2018; 14(2): 145-52.
 [http://dx.doi.org/10.1183/20734735.001918] [PMID:  29875834]

[18]
Novembre E, Tosca M, Caffarelli C, et al. Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5–11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP). Ital J Pediatr  2022; 48(1): 76.
 [http://dx.doi.org/10.1186/s13052-022-01272-z] [PMID:  35578294]

[19]
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA  2020; 323(11): 1061-9.
 [http://dx.doi.org/10.1001/jama.2020.1585] [PMID:  32031570]

[20]
Pulvirenti G, Parisi GF, Giallongo A, et al. Lower airway microbiota. Front Pediatr  2019; 7: 393.
 [http://dx.doi.org/10.3389/fped.2019.00393] [PMID:  31612122]

[21]
Sankar J, Dhochak N, Kabra SK, Lodha R. COVID-19 in children: Clinical approach and management. Indian J Pediatr  2020; 87(6): 433-42.
 [http://dx.doi.org/10.1007/s12098-020-03292-1] [PMID:  32338347]

[22]
Zimmerman P, Curtis N. Coronavirus infections in Children Including COVID-29. Pediatr Infect Dis J  2020; 39(5): 355-68.

[23]
Irfan O, Muttalib F, Tang K, Jiang L, Lassi ZS, Bhutta Z. Clinical characteristics, treatment and outcomes of paediatric COVID-19: A systematic review and meta-analysis. Arch Dis Child  2021; 106(5): 440-8.
 [http://dx.doi.org/10.1136/archdischild-2020-321385] [PMID:  33593743]

[24]
La Tessa A, Motisi MA, Marseglia GL, et al. Use of remdesivir in children with COVID-19 infection: A quick narrative review. Acta Biomed  2021; 92(S7): e2021524.
 [http://dx.doi.org/10.23750/abm.v92iS7.12396] [PMID:  34842595]

[25]
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med  2020; 382(18): 1708-20.

[26]
Manti S, Licari A, Montagna L, et al. SARS-CoV-2 infection in pediatric population. Acta Biomed  2020; 91(11-S): e2020003.
 [http://dx.doi.org/10.23750/abm.v91i11-S.10298] [PMID:  33004773]

[27]
Cardinale F, Ciprandi G, Barberi S, et al. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital J Pediatr  2020; 46(1): 84.
 [http://dx.doi.org/10.1186/s13052-020-00843-2] [PMID:  32546234]

[28]
Zhang J, Zhou L, Yang Y, et al. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Respir Med  2019; 8(3): E11-2.

[29]
Emergency, point-of-care and clinical ultrasound guidelines in medicine. Ann Emerg Med  2017; 69(5): e27-54.
 [http://dx.doi.org/10.1016/j.annemergmed.2016.08.457] [PMID:  28442101]

[30]
Pereda MA, Chavez MA, Hooper-Miele CC, et al. Lung ultrasound for the diagnosis of pneumonia in children: A meta-analysis. Pediatrics  2015; 135(4): 714-22.
 [http://dx.doi.org/10.1542/peds.2014-2833] [PMID:  25780071]

[31]
Lichtenstein DA, Mezière G, Lascols N, et al. Ultrasound diagnosis of occult pneumothorax. Crit Care Med  2005; 33(6): 1231-8.
 [http://dx.doi.org/10.1097/01.CCM.0000164542.86954.B4] [PMID:  15942336]

[32]
Yousefifard M, Baikpour M, Ghelichkhani P, et al. Screening performance characteristic of ultrasonography and radiography in detection of pleural effusion; a meta-analysis. Emergency  2016; 4(1): 1-10.
 [PMID:  26862542]

[33]
Tierney DM, Huelster JS, Overgaard JD, et al. Comparative performance of pulmonary ultrasound, chest radiograph and CT among patients with acute respiratory failure. Crit Care Med  2020; 48(2): 151-7.
 [http://dx.doi.org/10.1097/CCM.0000000000004124] [PMID:  31939782]

[34]
Tung-Chen Y. Lung ultrasound in the monitoring of COVID-19 infection. Clin Med  2020; 20(4): e62-5.
 [http://dx.doi.org/10.7861/clinmed.2020-0123] [PMID:  32398268]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573398X19666230314161859	Print ISSN 1573-398X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6387

Current Respiratory Medicine Reviews

Follow-up COVID-19 and Lung Ultrasound are Fundamental to Prove Full Recovery in Children with Interstitial Lung Disease Requiring Oxygen: A Case Report

Abstract Play Pause

Graphical Abstract

Related Journals

Related Books

Abstract